EP2137219A1 - Method for making a polysaccharide dialdehyde having high purity - Google Patents

Method for making a polysaccharide dialdehyde having high purity

Info

Publication number
EP2137219A1
EP2137219A1 EP08743049A EP08743049A EP2137219A1 EP 2137219 A1 EP2137219 A1 EP 2137219A1 EP 08743049 A EP08743049 A EP 08743049A EP 08743049 A EP08743049 A EP 08743049A EP 2137219 A1 EP2137219 A1 EP 2137219A1
Authority
EP
European Patent Office
Prior art keywords
dialdehyde
polysaccharide
dextran
polysaccharide dialdehyde
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08743049A
Other languages
German (de)
French (fr)
Inventor
Jeffrey David Cohen
Henry Keith Chenault
Rinaldo S. Schiffino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actamax Surgical Materials LLC
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of EP2137219A1 publication Critical patent/EP2137219A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Definitions

  • the invention relates to the field of medical adhesives. More specifically, the invention relates to a method for making a polysaccharide dialdehyde in a highly pure form which is useful for the preparation of hydrogel adhesives for medical applications.
  • Tissue adhesives have many potential medical applications, including wound closure, supplementing or replacing sutures or staples in internal surgical procedures, adhesion of synthetic onlays or inlays to the cornea, drug delivery devices, and as anti-adhesion barriers to prevent post-surgical adhesions.
  • Conventional tissue adhesives are generally not suitable for a wide range of adhesive applications. For example, cyanoacrylate-based adhesives have been used for topical wound closure, but the release of toxic degradation products limits their use for internal applications. Fibrin-based adhesives are slow curing, have poor mechanical strength, and pose a risk of viral infection. Additionally, fibrin- based adhesives do not covalently bind to the underlying tissue.
  • hydrogel tissue adhesives have been developed, which have improved adhesive and cohesive properties and are nontoxic. These hydrogels are generally formed by reacting a component having nucleophilic groups with a component having electrophilic groups, which are capable of reacting with the nucleophilic groups of the first component, to form a crosslinked network via covalent bonding.
  • Polysaccharide dialdehydes have been used as the component having electrophilic groups for preparing these hydrogel adhesives because they are highly biocompatible and biodegradable (see for example, Kodokian et al., copending and commonly owned U.S. Patent Application Publication No. 2006/0078536, and Goldmann, U.S. Patent Application Publication No. 2005/0002893).
  • the polysaccharide dialdehydes are typically formed by oxidation of the polysaccharide with periodate (Mo et al. J. Biomater. Sci. Polymer Edn. 11 :341-351 , (2000); and Halsall et al., J. Chem. Soc. 1947, 1427-1432).
  • the amount of unreacted periodate and iodine-containing byproducts in the polysaccharide dialdehyde preparation must be reduced to low levels to prevent toxic effects. Consequently, the polysaccharide dialdehyde is typically purified by extensive dialysis to remove the iodine containing species (Kodokian et al.
  • iodate may be separated from dextran dialdehyde, prepared by the oxidation of dextran with periodate, using an ion exchange resin, as described by Seitz et al. (Journal for Praktishe Chemie (Leipzig) 311(1):141-146 (1969)).
  • the problem to be solved is to provide a method for making polysaccharide dialdehydes that provides a product that has a low level of iodine-containing species and is simple and rapid.
  • Applicants have addressed the stated problem by discovering a method of making polysaccharide dialdehydes that comprises a combination of precipitation and separation steps to purify the polysaccharide dialdehyde formed by oxidation of the polysaccharide with periodate.
  • the method provides a polysaccharide dialdehyde with very low levels of iodine-containing species.
  • the invention provides an improved method for making a polysaccharide dialdehyde by a process that comprises reacting a polysaccharide with at least one periodate salt at a temperature above about 10 0 C to produce a product comprising said polysaccharide dialdehyde, iodate in the form of at least one iodate salt, and optionally periodate in the form of at least one unreacted periodate salt, the improvement comprising the steps of: a) adding a source of at least one cation, which is capable of precipitating at least a portion of the iodate, to said product thereby forming a precipitate comprising said at least one cation and iodate, and a supernatant fluid that comprises the polysaccharide dialdehyde; b) separating at least a portion of the precipitate from the supernatant fluid; c) adding at least one iodide salt to the supernatant fluid thereby forming a mixture comprising the poly
  • the invention provides an improved method for making a polysaccharide dialdehyde by a process that comprises reacting a polysaccharide with at least one periodate salt at a temperature above about 10 0 C to produce a product comprising said polysaccharide dialdehyde, iodate in the form of at least one iodate salt, and optionally periodate in the form of at least one unreacted periodate salt, the improvement comprising the steps of: a) cooling said product to a crystallization temperature below about 5 0 C and maintaining said product at the crystallization temperature for a time sufficient to form a precipitate comprising at least one periodate salt and a first supernatant fluid that comprises polysaccharide dialdehyde; b) separating at least a portion of the precipitate from the first supernatant fluid; c) adding a source of at least one cation, which is capable of precipitating at least a portion of the iodate, to the first supernatant fluid thereby
  • a method for making polysaccharide dialdehydes which uses a combination of precipitation and separation steps to purify the polysaccharide dialdehyde formed by oxidation of a polysaccharide with periodate.
  • the method is simple, rapid, and provides a polysaccharide dialdehyde having very low levels of iodine-containing species, specifically, less than about 0.03% by weight elemental iodine.
  • the low level of iodine-containing species makes the polysaccharide dialdehydes particularly useful for preparing hydrogel adhesives for medical and veterinary applications, including, but not limited to, wound closure, supplementing or replacing sutures or staples in internal surgical procedures such as intestinal anastomosis and vascular anastomosis, tissue repair, ophthalmic procedures, drug delivery, and in anti-adhesive applications.
  • the resulting polysaccharide dialdehyde product has a higher bulk density than polysaccharide dialdehydes that are purified by dialysis and subsequently lyophilized. The higher bulk density facilitates the transportation and storage of the polysaccharide dialdehyde.
  • polysaccharide dialdehyde or “oxidized polysaccharide” are used interchangeably herein to refer to a polysaccharide which has been reacted with periodate to introduce aldehyde groups into the molecule.
  • water-dispersible, multi-arm polyether amine refers to a branched polyether, wherein at least three of the branches ("arms") are terminated by a primary amine group, which is water soluble or able to be dispersed in water to form a colloidal suspension capable of reacting with a second reactant in aqueous solution or dispersion.
  • polyether refers to a polymer having the repeat unit [-O-
  • R is a hydrocarbylene group having 2 to 5 carbon atoms.
  • tissue refers to any tissue, both living and dead, in humans or animals.
  • hydrogel refers to a water-swellable polymeric matrix, consisting of a three-dimensional network of macromolecules held together by covalent or non-covalent crosslinks, that can absorb a substantial amount of water to form an elastic gel.
  • a polysaccharide is oxidized to produce a polysaccharide dialdehyde using periodate.
  • the polysaccharide dialdehyde is then separated from excess periodate and iodine-containing byproducts using a series of precipitation and separation steps, as described below.
  • Polysaccharides useful in the invention include, but are not limited to, dextran, starch, cellulose, hemicellulose, methyl cellulose, ethyl cellulose, chondroitin sulfate, dextran sulfate, and hyaluronic acid. These polysaccharides are available commercially from sources such as Sigma Chemical Co. (St Louis, MO).
  • the polysaccharide is dextran.
  • polysaccharides are a heterogeneous mixture having a distribution of different molecular weights, and are characterized by an average molecular weight, for example, the weight-average molecular weight (M w ), or the number average molecular weight (M n ), as is known in the art.
  • Suitable polysaccharides have a weight-average molecular weight from about 1 ,000 to about 1 ,000,000 Daltons, preferably from about 3,000 ' to about 250,000 Daltons.
  • the polysaccharide is dextran having a weight-average molecular weight of about 8,500 to 11 ,500 Daltons.
  • the polysaccharide is dextran having a weight-average molecular weight of about 60,000 to 90,000 Daltons.
  • the polysaccharide is oxidized to introduce aldehyde groups by reaction with periodate in an aqueous solution using any suitable periodate salt, for example, sodium periodate or potassium periodate, as is known in the art (see for example, Mo et al. J. Biomater. Sci. Polymer Edn. 11 :341-351 , (2000); Halsall et al., J. Chem. Soc. 1947, 1427-1432); Kodokian et al. supra; and Goldmann, supra).
  • the polysaccharide may be reacted with different amounts of periodate to give polysaccharides with different degrees of oxidation and therefore, a different dialdehyde content.
  • a polysaccharide is reacted with at least one periodate salt at a temperature above about 10 0 C to produce a product comprising a polysaccharide dialdehyde, and iodate in the form of at least one iodate salt. Additionally, if an excess of periodate is used in the reaction, the product will also contain periodate in the form of at least one unreacted periodate salt.
  • the temperature used for the oxidation reaction is typically from about 11 0 C to about 70 0 C, preferably from about 20 0 C to about 60 0 C. It should be noted that the oxidation reaction is an exothermic process that causes the temperature of the solution to rise. Consequently, the solution may need to be cooled to attain the desired temperature.
  • an aqueous dextran solution is reacted with an aqueous solution of sodium periodate at a temperature of about 20 0 C to 30 0 C for a period of about 3.5 to about 5 hours.
  • the product of the oxidation reaction is cooled to a crystallization temperature below about 5 C C, preferably between about 2 0 C and about -8 0 C and maintained at a crystallization temperature for a time sufficient to form a precipitate comprising at least one periodate salt and a first supernatant fluid that comprises the polysaccharide dialdehyde.
  • the time required will vary depending on the particular conditions used (e.g., the volume of the product and the temperature), but is typically from about 5 minutes to about 60 minutes. Preferably, the time is not long enough for the entire product to freeze.
  • This cooling may be carried out in two separate steps wherein the reaction product is rapidly cooled to one crystallization temperature, specifically below about 5 0 C for a period of time, typically from about 5 minutes to about 40 minutes, to form the precipitate. Then, the reaction mixture is maintained at a second crystallization temperature, specifically below about 5 0 C, which is different from the first crystallization temperature, for a time sufficient to crystallize the periodate salt, typically from about 20 minutes to about 55 minutes, preferably about 30 minutes.
  • the cooling step is optional, but is particularly beneficial when an excess of periodate is used in the oxidation reaction.
  • At least a portion of the precipitate is separated from the first supernatant fluid using methods known in the art, for example, filtering, decanting, centrifuging, or siphoning off the first supernatant fluid. Ideally, substantially all of the precipitate is separated from the first supernatant fluid.
  • iodate is precipitated out as an insoluble salt by adding a source of at least one cation, which is capable of precipitating at least a portion of the iodate, to the first supernatant fluid thereby forming a second precipitate comprising the cation(s) and iodate, and a second supernatant fluid that comprises the polysaccharide dialdehyde.
  • the cation(s) is /are capable of precipitating substantially all of the iodate.
  • the source of the cation(s) is at least one soluble salt comprising a cation that forms a salt with iodate that has a low solubility in aqueous solution. Suitable cations include, but are not limited to, Ca 2+ , Sr 2+ , Ba 2+ , Mn 2+ , Cu 2+ ,
  • Suitable soluble salts include, but are not limited to, calcium chloride, calcium acetate, calcium bromide, strontium chloride, strontium acetate, barium chloride, barium acetate, manganese chloride, manganese acetate, cupric chloride, cupric acetate, zinc chloride, zinc acetate, silver nitrate, cadmium chloride, cadmium acetate, lead chloride, lead acetate, mercuric chloride, and mercuric acetate.
  • Preferred soluble salts for the preparation of polysaccharide dialdehydes to be used for medical applications include calcium chloride, calcium acetate, calcium bromide, manganese chloride, manganese acetate, zinc chloride, zinc acetate, cupric chloride, and cupric acetate.
  • the salt is calcium chloride. This step is typically done at room temperature (e.g., 20 0 C to 25 0 C) for a period of at least about 30 minutes. Then, at least a portion of the second precipitate is separated from the second supernatant fluid using methods known in the art, for example, filtering, decanting, centrifuging, or siphoning off the second supernatant fluid. Ideally, substantially all of the second precipitate is separated from the second supernatant fluid.
  • At least one iodide salt is then added to the second supernatant fluid, thereby forming a mixture comprising the polysaccharide dialdehyde and molecular iodine.
  • Any suitable iodide salt may be used including, but not limited to, sodium iodide, potassium iodide, lithium iodide, calcium iodide, or ammonium iodide.
  • the iodide salt is potassium iodide. This step is typically done at room temperature (e.g., 20 0 C to 25 0 C) for a period of at least about 30 minutes.
  • the mixture is optionally filtered to remove the iodine and obtain a filtrate that comprises the polysaccharide dialdehyde.
  • the iodine may be removed by allowing it to sublime.
  • a first organic solvent is added to either the mixture or the filtrate in an amount sufficient to cause at least some of the polysaccharide dialdehyde to separate from the mixture or the filtrate, thereby forming a first phase comprising the polysaccharide and a second phase comprising the organic solvent.
  • Suitable first organic solvents include, but are not limited to, acetone, methyl ethyl ketone, tetrahydrofuran (THF), methanol, ethanol, and isopropanol.
  • the first organic solvent is acetone.
  • the amount of the first organic solvent will vary depending on the conditions, and the optimum amount can be readily determined using routine experimentation by one skilled in the art. Typically, the amount of first organic solvent used is about three times the mass of the reaction mixture or the filtrate. This step is typically done at room temperature (e.g., 20 0 C to 25 °C) for a time of at least about 30 minutes. At least a portion of the first phase is separated from the second phase using methods known in the art (e.g., filtering, decanting, centrifuging, or siphoning) to provide a separated polysaccharide dialdehyde. Ideally, substantially all of the first phase is separated from the second phase.
  • methods known in the art e.g., filtering, decanting, centrifuging, or siphoning
  • the separated polysaccharide dialdehyde is then contacted with an amount of a second organic solvent sufficient to harden the separated polysaccharide dialdehyde, thereby forming a hardened polysaccharide dialdehyde.
  • Suitable second organic solvents include, but are not limited to, methanol, ethanol, isopropanol, butanol, and acetonitrile. In one embodiment the second organic solvent is methanol.
  • the amount of the second organic solvent will vary depending on the conditions, and the optimum amount can be readily determined using routine experimentation by one skilled in the art. Typically the amount of second organic solvent used is from about 25% to about 100% of the volume of the first organic solvent, as described above.
  • the hardened polysaccharide dialdehyde is comminuted to form a particulate polysaccharide dialdehyde.
  • the comminuting reduces the particulate polysaccharide to a powder and can be done using methods known in the art, for example, grinding, milling, or crushing with a mortar and pestle.
  • the particulate polysaccharide dialdehyde may be dried using any suitable method, for example, using heat, vacuum, a combination of heat and vacuum, or flowing a stream of dry air or a dry inert gas such as nitrogen over the particulate polysaccharide dialdehyde.
  • the particulate polysaccharide dialdehyde is then contacted with a cold aqueous liquid at a temperature of less than about 10 0 C, preferably from about -15 0 C to about 5 0 C, for a time sufficient to remove at least some of the iodine-containing species from the particulate polysaccharide dialdehyde, thereby forming a purified polysaccharide dialdehyde.
  • substantially all of the iodine-containing species are removed from the particulate polysaccharide.
  • the cold aqueous liquid may be pure water or comprise a mixture of water and a water-soluble organic solvent such as methanol, ethanol, or isopropanol.
  • the mixture contains less than or equal to about 50% of the water-miscible organic solvent by volume, preferably from about 5% to about 50% by volume.
  • the cold aqueous liquid is pure water at a temperature of about 0 0 C to about 5 0 C.
  • the cold aqueous liquid is a mixture comprising water and 30 to 40% methanol by volume at a temperature of about -15 0 C to about 5 0 C. The time of contacting needs to be optimized to maximize the purity of the polysaccharide dialdehyde while minimizing its loss due to dissolution in the cold aqueous liquid.
  • the solubility and the rate of dissolution of the polysaccharide dialdehyde in the cold aqueous liquid depend on several factors such as its molecular weight and degree of oxidation.
  • the contact time is from about 30 seconds to about 4 hours, preferably from about 10 minutes to about 60 minutes.
  • At least a portion of the purified polysaccharide dialdehyde is then recovered from the cold aqueous liquid using filtering, decanting, centrifuging, siphoning, or the like.
  • substantially all of the purified polysaccharide dialdehyde is recovered from the cold aqueous liquid.
  • the contacting with cold aqueous liquid may be repeated one or more times.
  • the purified polysaccharide dialdehyde may be dried using any suitable method, for example, using heat, vacuum, a combination of heat and vacuum, or flowing a stream of dry air or a dry inert gas such as nitrogen over the purified polysaccharide dialdehyde.
  • the purified polysaccharide dialdehyde is dried in a vacuum oven at 20 °C for about 16 to 24 hours.
  • the product of the oxidation reaction is not cooled to a temperature below about 5 0 C, i.e., the optional first step is omitted, and the method is followed as described above from the step that comprises adding a source of at least one cation that is capable of precipitating at least a portion of the iodate.
  • the cation(s) is/are capable of precipitating substantially all of the iodate.
  • a source of at least one cation is added to the product of the oxidation reaction, thereby forming a precipitate comprising the cation(s) and iodate, and a supernatant fluid.
  • At least a portion of the precipitate is separated from the supernatant fluid using methods as described above. Ideally, substantially all of the precipitate is separated from the supernatant fluid.
  • at least one iodide salt is added to the supernatant fluid thereby forming a mixture comprising the polysaccharide dialdehyde and molecular iodine.
  • the mixture is optionally filtered to obtain a filtrate.
  • a first organic solvent is added to the mixture or the filtrate in an amount sufficient to cause at least some of the polysaccharide dialdehyde to separate from the mixture or the filtrate, thereby forming a first phase comprising the polysaccharide dialdehyde and a second phase comprising the organic solvent.
  • substantially all of the polysaccharide dialdehyde is separated from the mixture or the filtrate. At least a portion of the first phase is separated from the second phase using methods as described above, to provide a separated polysaccharide dialdehyde. Ideally, substantially all of the first phase is separated from the second phase.
  • the separated polysaccharide dialdehyde is then contacted with an amount of a second organic solvent sufficient to harden the separated polysaccharide dialdehyde, thereby forming a hardened separated polysaccharide dialdehyde.
  • the hardened polysaccharide dialdehyde is comminuted to form particulate polysaccharide dialdehyde.
  • the particulate polysaccharide dialdehyde may be dried as described above.
  • the particulate polysaccharide dialdehyde is then contacted with a cold aqueous liquid at a temperature below about 10 0 C for a time sufficient to remove at least some iodine containing species from the particulate polysaccharide dialdehyde, thereby forming a purified polysaccharide dialdehyde.
  • substantially all of the iodine containing species are removed from the particulate polysaccharide dialdehyde.
  • the contacting with cold aqueous liquid may be repeated one or more times.
  • at least a portion of the purified polysaccharide dialdehyde is recovered as described above.
  • substantially all of the purified polysaccharide dialdehyde is recovered.
  • the purified polysaccharide dialdehyde may be dried, as described above.
  • the amount of iodine-containing species remaining in the purified polysaccharide dialdehyde can be determined using methods known in the art. For example, the total amount of elemental iodine in any form remaining in the purified polysaccharide dialdehyde can be determined using X-ray fluorescence spectrometry. Typically, the amount of elemental iodine remaining in the polysaccharide dialdehyde produced by the method disclosed herein is less than about 0.03 wt%. After the purified polysaccharide dialdehyde is recovered and optionally dried, it may be used to prepare hydrogel adhesives for medical applications by reacting it in an aqueous medium with a polyamine having three or more amine groups.
  • the purified polysaccharide dialdehyde may be reacted with a water-dispersible, multi-arm polyether amine to form a hydrogel tissue adhesive as described by Kodokian et al. (copending and commonly owned U.S. Patent Application Publication No. 2006/0078536, which is incorporated herein by reference).
  • the resulting hydrogel may be used for medical and veterinary applications, including, but not limited to, wound closure, supplementing or replacing sutures or staples in internal surgical procedures such as intestinal anastomosis and vascular anastomosis, tissue repair, ophthalmic procedures, drug delivery, and in anti-adhesive applications.
  • the purpose of this Example was to prepare dextran dialdehyde having an average molecular weight of 8,500 to 11 ,500 Daltons and a total iodine content of less than 0.03 wt%.
  • the reactor contents were transferred to a beaker and the beaker was chilled in an ice/acetone bath until a precipitate comprising a periodate salt was formed.
  • the mixture was then transferred back to the reactor and stirred for 30 min at 2 0 C.
  • the reactor contents were filtered, yielding 17.13 g of solids.
  • the filtrate was transferred to a beaker and 18.75 g of CaCI 2 .2H 2 O was added to the filtrate.
  • the mixture was stirred for 30 min at room temperature forming a precipitate comprising calcium iodate.
  • the precipitate was filtered, yielding 21.45 g of solids.
  • the filtrate was transferred to a beaker and 15.0 g of potassium iodide was added to the filtrate. The mixture was stirred for 30 min at room temperature. The mixture was filtered, but did not result in any detectable amount of solids being collected.
  • the filtrate was transferred to a plastic jug and 2 L of acetone was slowly added to separate the dextran dialdehyde from the filtrate. The contents in the jug were stirred for 30 min, after which time the acetone was decanted off to collect the precipitated solid.
  • the solids were washed with methanol (1 L) and transferred to a blender to be chopped at high speed in the presence of methanol. The solids were filtered and dried under vacuum.
  • the solid product was analyzed using X-ray fluorescence spectrometry and was found to contain 0.215 wt% chlorine, 0.017 wt% iodine, 0.198 wt% calcium, 0.0272 wt% sodium and 0.237 wt% potassium, and an overall purity of 99.02 wt%.
  • the purpose of this Example was to prepare dextran dialdehyde having an average molecular weight of 60,000 to 90,000 Daltons and a total iodine content of less than 0.03 wt%.
  • Example 2 The procedure described in Example 1 was used except that the dextran had an average molecular weight of 60,000 to 90,000 Daltons (Sigma Chemical Co, St Louis, MO, catalog no. D3759) and the amount of sodium periodate used was 18.75 g.
  • the dialdehyde content of the product was determined to be 28% using proton NMR.
  • the solid product was analyzed using X-ray fluorescence spectrometry and was found to contain 0.225 wt% chlorine, 0.019 wt% iodine, 0.0475 wt% calcium, and 0.185 wt% potassium, and an overall purity of 99.98 wt%.
  • EXAMPLE 3 EXAMPLE 3
  • a 20-L reactor equipped with a mechanical stirrer, addition funnel, internal thermocouple, and nitrogen purge was charged with 1.00 kg of dextran and 9.00 L of water.
  • the mixture was stirred at ambient temperature to dissolve the dextran, and the solution was cooled to 10-15 0 C.
  • a solution of 500 g of sodium periodate in 9.00 L of water was added to the reactor over about an hour while keeping the temperature of the reactor contents below 25 0 C. After the sodium periodate solution was added, the mixture was stirred at 20-25 °C for 4 h.
  • 350 g of CaCI 2 -2H 2 O was added to the reaction mixture and the mixture was stirred at ambient temperature for 1 h, forming a precipitate comprising calcium iodate.
  • the mixture was filtered to remove the precipitate, and 200 g of potassium iodide was added to the filtrate.
  • the potassium iodide-containing filtrate was stirred at ambient temperature for 30 min and then filtered, giving a second filtrate.
  • a 5- gallon, plastic pail equipped with a mechanical stirrer was charged with 9.0 L of acetone.
  • About 3.0 L of the second filtrate was added to the acetone over about 15 min with stirring, producing a soft, rubbery precipitate.
  • the supernatant liquid was decanted, and the rubbery precipitate was collected.
  • the rest of the second filtrate was processed similarly, adding it in portions to acetone, stirring, and decanting to collect the precipitate.
  • the combined precipitate from acetone was broken up into pieces and washed in portions with methanol in a large stainless steel blender.
  • the precipitated dextran dialdehyde was collected by filtration, dried under vacuum with a nitrogen blanket, and hammer-milled to a fine powder.
  • a 20-L reactor was charged with 18.0 L of deionized water and cooled to about 0 0 C.
  • the hammer-milled dextran dialdehyde was added and stirred vigorously for 1 h.
  • the slurry of dextran dialdehyde in cold water was discharged in portions and filtered to collect the solid, which was immediately washed with methanol to remove water from the product.
  • the solid was dried under vacuum with a nitrogen purge to give 789 g of white, granular dextran dialdehyde.
  • the dialdehyde content of the product was determined to be 27% using proton NMR.
  • the solid product was analyzed using X-ray fluorescence spectrometry and was found to contain 0.271 wt% sodium, 0.0922 wt% chlorine, 0.0723 wt% potassium, 0.0327 wt% calcium and 0.0068 wt% iodine, and an overall purity of 99.2 wt%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

A method for making polysaccharide dialdehydes is disclosed, which uses a combination of precipitation and separation steps to purify the polysaccharide dialdehyde formed by oxidation of a polysaccharide with periodate. The method is simple, rapid, and provides a polysaccharide dialdehyde having very low levels of iodine-containing species. The polysaccharide dialdehyde is particularly suitable for preparing hydrogel adhesives for medical applications.

Description

TITLE
METHOD FOR MAKING A POLYSACCHARIDE DIALDEHYDE HAVING HIGH PURITY
CROSS-REFERENCE TO RELATED APPLICATION This application claims priority from U.S. Provisional Application
Serial No. 60/925,948 (filed April 20, 2007), the disclosure of which is incorporated by reference herein for all purposes as if fully set forth.
FIELD OF THE INVENTION The invention relates to the field of medical adhesives. More specifically, the invention relates to a method for making a polysaccharide dialdehyde in a highly pure form which is useful for the preparation of hydrogel adhesives for medical applications.
BACKGROUND OF THE INVENTION Tissue adhesives have many potential medical applications, including wound closure, supplementing or replacing sutures or staples in internal surgical procedures, adhesion of synthetic onlays or inlays to the cornea, drug delivery devices, and as anti-adhesion barriers to prevent post-surgical adhesions. Conventional tissue adhesives are generally not suitable for a wide range of adhesive applications. For example, cyanoacrylate-based adhesives have been used for topical wound closure, but the release of toxic degradation products limits their use for internal applications. Fibrin-based adhesives are slow curing, have poor mechanical strength, and pose a risk of viral infection. Additionally, fibrin- based adhesives do not covalently bind to the underlying tissue. Several types of hydrogel tissue adhesives have been developed, which have improved adhesive and cohesive properties and are nontoxic. These hydrogels are generally formed by reacting a component having nucleophilic groups with a component having electrophilic groups, which are capable of reacting with the nucleophilic groups of the first component, to form a crosslinked network via covalent bonding. Polysaccharide dialdehydes have been used as the component having electrophilic groups for preparing these hydrogel adhesives because they are highly biocompatible and biodegradable (see for example, Kodokian et al., copending and commonly owned U.S. Patent Application Publication No. 2006/0078536, and Goldmann, U.S. Patent Application Publication No. 2005/0002893). The polysaccharide dialdehydes are typically formed by oxidation of the polysaccharide with periodate (Mo et al. J. Biomater. Sci. Polymer Edn. 11 :341-351 , (2000); and Halsall et al., J. Chem. Soc. 1947, 1427-1432). For medical applications of these hydrogel adhesives, the amount of unreacted periodate and iodine-containing byproducts in the polysaccharide dialdehyde preparation must be reduced to low levels to prevent toxic effects. Consequently, the polysaccharide dialdehyde is typically purified by extensive dialysis to remove the iodine containing species (Kodokian et al. supra; Goldmann, supra; Bondarev et al. SU 1541218; and Uraz et al., Carbohydrate Polymers 34:127-130 (1997)). However, dialysis is a slow process requiring many days and therefore, is not well suited to the large scale production of polysaccharide dialdehydes. Alternatively, iodate may be separated from dextran dialdehyde, prepared by the oxidation of dextran with periodate, using an ion exchange resin, as described by Seitz et al. (Journal for Praktishe Chemie (Leipzig) 311(1):141-146 (1969)).
Therefore, the problem to be solved is to provide a method for making polysaccharide dialdehydes that provides a product that has a low level of iodine-containing species and is simple and rapid.
Applicants have addressed the stated problem by discovering a method of making polysaccharide dialdehydes that comprises a combination of precipitation and separation steps to purify the polysaccharide dialdehyde formed by oxidation of the polysaccharide with periodate. The method provides a polysaccharide dialdehyde with very low levels of iodine-containing species.
SUMMARY OF THE INVENTION Disclosed herein is a method for making polysaccharide dialdehydes that is simple, rapid, and produces product with very low levels of iodine-containing species.
Accordingly, in one embodiment the invention provides an improved method for making a polysaccharide dialdehyde by a process that comprises reacting a polysaccharide with at least one periodate salt at a temperature above about 10 0C to produce a product comprising said polysaccharide dialdehyde, iodate in the form of at least one iodate salt, and optionally periodate in the form of at least one unreacted periodate salt, the improvement comprising the steps of: a) adding a source of at least one cation, which is capable of precipitating at least a portion of the iodate, to said product thereby forming a precipitate comprising said at least one cation and iodate, and a supernatant fluid that comprises the polysaccharide dialdehyde; b) separating at least a portion of the precipitate from the supernatant fluid; c) adding at least one iodide salt to the supernatant fluid thereby forming a mixture comprising the polysaccharide dialdehyde and molecular iodine; d) optionally filtering the mixture to obtain a filtrate; e) adding a first organic solvent to the mixture of (c) or the filtrate of (d) in an amount sufficient to cause at least some of the polysaccharide dialdehyde to separate from the mixture of (c) or the filtrate of (d), thereby forming a first phase comprising the polysaccharide dialdehyde and a second phase comprising the organic solvent; f) separating at least a portion of the first phase from the second phase to provide a separated polysaccharide dialdehyde; g) contacting the separated polysaccharide dialdehyde with an amount of a second organic solvent sufficient to harden the separated polysaccharide dialdehyde, thereby forming hardened polysaccharide dialdehyde; h) comminuting the hardened polysaccharide dialdehyde to form particulate polysaccharide dialdehyde; i) contacting the particulate polysaccharide dialdehyde with a cold aqueous liquid at a temperature of less than about 10 0C for a time sufficient to remove at least some iodine-containing species from the particulate polysaccharide dialdehyde, thereby forming a purified polysaccharide dialdehyde; and j) recovering at least a portion of the purified polysaccharide dialdehyde from the cold aqueous liquid.
In another embodiment, the invention provides an improved method for making a polysaccharide dialdehyde by a process that comprises reacting a polysaccharide with at least one periodate salt at a temperature above about 10 0C to produce a product comprising said polysaccharide dialdehyde, iodate in the form of at least one iodate salt, and optionally periodate in the form of at least one unreacted periodate salt, the improvement comprising the steps of: a) cooling said product to a crystallization temperature below about 5 0C and maintaining said product at the crystallization temperature for a time sufficient to form a precipitate comprising at least one periodate salt and a first supernatant fluid that comprises polysaccharide dialdehyde; b) separating at least a portion of the precipitate from the first supernatant fluid; c) adding a source of at least one cation, which is capable of precipitating at least a portion of the iodate, to the first supernatant fluid thereby forming a second precipitate comprising said at least one cation and iodate, and a second supernatant fluid that comprises the polysaccharide dialdehyde; d) separating at least a portion of the second precipitate from the second supernatant fluid; e) adding at least one iodide salt to the second supernatant fluid thereby forming a mixture comprising the polysaccharide dialdehyde and molecular iodine; f) optionally filtering the mixture to obtain a filtrate; g) adding a first organic solvent to the mixture of (e) or the filtrate of [T) in an amount sufficient to cause at least some of the polysaccharide dialdehyde to separate from the mixture of (e) or the filtrate of (T), thereby forming a first phase comprising the polysaccharide dialdehyde and a second phase comprising the organic solvent; h) separating at least a portion of the first phase from the second phase to provide a separated polysaccharide dialdehyde; i) contacting the separated polysaccharide dialdehyde with an amount of a second organic solvent sufficient to harden the separated polysaccharide dialdehyde, thereby forming hardened polysaccharide dialdehyde; j) comminuting the hardened polysaccharide dialdehyde to form particulate polysaccharide dialdehyde; k) contacting the particulate polysaccharide dialdehyde with a cold aqueous liquid at a temperature of less than about 10 0C for a time sufficient to remove at least some iodine containing species from the particulate polysaccharide dialdehyde, thereby forming a purified polysaccharide dialdehyde; and I) recovering at least a portion of the purified polysaccharide dialdehyde from the cold aqueous liquid.
DETAILED DESCRIPTION OF THE INVENTION Disclosed herein is a method for making polysaccharide dialdehydes, which uses a combination of precipitation and separation steps to purify the polysaccharide dialdehyde formed by oxidation of a polysaccharide with periodate. The method is simple, rapid, and provides a polysaccharide dialdehyde having very low levels of iodine-containing species, specifically, less than about 0.03% by weight elemental iodine. The low level of iodine-containing species makes the polysaccharide dialdehydes particularly useful for preparing hydrogel adhesives for medical and veterinary applications, including, but not limited to, wound closure, supplementing or replacing sutures or staples in internal surgical procedures such as intestinal anastomosis and vascular anastomosis, tissue repair, ophthalmic procedures, drug delivery, and in anti-adhesive applications. Additionally, the resulting polysaccharide dialdehyde product has a higher bulk density than polysaccharide dialdehydes that are purified by dialysis and subsequently lyophilized. The higher bulk density facilitates the transportation and storage of the polysaccharide dialdehyde. The following definitions are used herein and should be referred to for interpretation of the claims and the specification. The terms "polysaccharide dialdehyde" or "oxidized polysaccharide" are used interchangeably herein to refer to a polysaccharide which has been reacted with periodate to introduce aldehyde groups into the molecule. The term "water-dispersible, multi-arm polyether amine" refers to a branched polyether, wherein at least three of the branches ("arms") are terminated by a primary amine group, which is water soluble or able to be dispersed in water to form a colloidal suspension capable of reacting with a second reactant in aqueous solution or dispersion. The term "polyether" refers to a polymer having the repeat unit [-O-
R]-, wherein R is a hydrocarbylene group having 2 to 5 carbon atoms.
The term "tissue" refers to any tissue, both living and dead, in humans or animals.
The term "hydrogel" refers to a water-swellable polymeric matrix, consisting of a three-dimensional network of macromolecules held together by covalent or non-covalent crosslinks, that can absorb a substantial amount of water to form an elastic gel.
By medical application is meant medical applications as related to humans and animals. In the method disclosed herein, a polysaccharide is oxidized to produce a polysaccharide dialdehyde using periodate. The polysaccharide dialdehyde is then separated from excess periodate and iodine-containing byproducts using a series of precipitation and separation steps, as described below. Polysaccharides useful in the invention include, but are not limited to, dextran, starch, cellulose, hemicellulose, methyl cellulose, ethyl cellulose, chondroitin sulfate, dextran sulfate, and hyaluronic acid. These polysaccharides are available commercially from sources such as Sigma Chemical Co. (St Louis, MO). In one embodiment, the polysaccharide is dextran. Typically, polysaccharides are a heterogeneous mixture having a distribution of different molecular weights, and are characterized by an average molecular weight, for example, the weight-average molecular weight (Mw), or the number average molecular weight (Mn), as is known in the art. Suitable polysaccharides have a weight-average molecular weight from about 1 ,000 to about 1 ,000,000 Daltons, preferably from about 3,000 ' to about 250,000 Daltons. In one embodiment the polysaccharide is dextran having a weight-average molecular weight of about 8,500 to 11 ,500 Daltons. In another embodiment, the polysaccharide is dextran having a weight-average molecular weight of about 60,000 to 90,000 Daltons.
The polysaccharide is oxidized to introduce aldehyde groups by reaction with periodate in an aqueous solution using any suitable periodate salt, for example, sodium periodate or potassium periodate, as is known in the art (see for example, Mo et al. J. Biomater. Sci. Polymer Edn. 11 :341-351 , (2000); Halsall et al., J. Chem. Soc. 1947, 1427-1432); Kodokian et al. supra; and Goldmann, supra). The polysaccharide may be reacted with different amounts of periodate to give polysaccharides with different degrees of oxidation and therefore, a different dialdehyde content. Specifically, a polysaccharide is reacted with at least one periodate salt at a temperature above about 10 0C to produce a product comprising a polysaccharide dialdehyde, and iodate in the form of at least one iodate salt. Additionally, if an excess of periodate is used in the reaction, the product will also contain periodate in the form of at least one unreacted periodate salt. The temperature used for the oxidation reaction is typically from about 11 0C to about 70 0C, preferably from about 20 0C to about 60 0C. It should be noted that the oxidation reaction is an exothermic process that causes the temperature of the solution to rise. Consequently, the solution may need to be cooled to attain the desired temperature. The time required for the reaction will vary depending on a number of factors, including the temperature and the concentration of the polysaccharide and periodate used. Typical reaction times range from about 30 minutes to about 6 hours. In one embodiment, an aqueous dextran solution is reacted with an aqueous solution of sodium periodate at a temperature of about 20 0C to 30 0C for a period of about 3.5 to about 5 hours.
In one embodiment, the product of the oxidation reaction is cooled to a crystallization temperature below about 5 CC, preferably between about 2 0C and about -8 0C and maintained at a crystallization temperature for a time sufficient to form a precipitate comprising at least one periodate salt and a first supernatant fluid that comprises the polysaccharide dialdehyde. The time required will vary depending on the particular conditions used (e.g., the volume of the product and the temperature), but is typically from about 5 minutes to about 60 minutes. Preferably, the time is not long enough for the entire product to freeze. This cooling may be carried out in two separate steps wherein the reaction product is rapidly cooled to one crystallization temperature, specifically below about 5 0C for a period of time, typically from about 5 minutes to about 40 minutes, to form the precipitate. Then, the reaction mixture is maintained at a second crystallization temperature, specifically below about 5 0C, which is different from the first crystallization temperature, for a time sufficient to crystallize the periodate salt, typically from about 20 minutes to about 55 minutes, preferably about 30 minutes. The cooling step is optional, but is particularly beneficial when an excess of periodate is used in the oxidation reaction. Then, at least a portion of the precipitate is separated from the first supernatant fluid using methods known in the art, for example, filtering, decanting, centrifuging, or siphoning off the first supernatant fluid. Ideally, substantially all of the precipitate is separated from the first supernatant fluid.
Next, iodate is precipitated out as an insoluble salt by adding a source of at least one cation, which is capable of precipitating at least a portion of the iodate, to the first supernatant fluid thereby forming a second precipitate comprising the cation(s) and iodate, and a second supernatant fluid that comprises the polysaccharide dialdehyde. Ideally, the cation(s) is /are capable of precipitating substantially all of the iodate. The source of the cation(s) is at least one soluble salt comprising a cation that forms a salt with iodate that has a low solubility in aqueous solution. Suitable cations include, but are not limited to, Ca2+, Sr2+, Ba2+, Mn2+ , Cu2+,
Zn2+ , Pb2+, Ag+ , Cd2+, and Hg2+. If the polysaccharide dialdehyde is to be used for medical applications, a cation with low toxicity is preferred, for
2+ 2+ 2+ 2+ example, Ca , Mn , Zn , or Cu . Suitable soluble salts include, but are not limited to, calcium chloride, calcium acetate, calcium bromide, strontium chloride, strontium acetate, barium chloride, barium acetate, manganese chloride, manganese acetate, cupric chloride, cupric acetate, zinc chloride, zinc acetate, silver nitrate, cadmium chloride, cadmium acetate, lead chloride, lead acetate, mercuric chloride, and mercuric acetate. Preferred soluble salts for the preparation of polysaccharide dialdehydes to be used for medical applications include calcium chloride, calcium acetate, calcium bromide, manganese chloride, manganese acetate, zinc chloride, zinc acetate, cupric chloride, and cupric acetate. In one embodiment, the salt is calcium chloride. This step is typically done at room temperature (e.g., 20 0C to 25 0C) for a period of at least about 30 minutes. Then, at least a portion of the second precipitate is separated from the second supernatant fluid using methods known in the art, for example, filtering, decanting, centrifuging, or siphoning off the second supernatant fluid. Ideally, substantially all of the second precipitate is separated from the second supernatant fluid.
At least one iodide salt is then added to the second supernatant fluid, thereby forming a mixture comprising the polysaccharide dialdehyde and molecular iodine. Any suitable iodide salt may be used including, but not limited to, sodium iodide, potassium iodide, lithium iodide, calcium iodide, or ammonium iodide. In one embodiment, the iodide salt is potassium iodide. This step is typically done at room temperature (e.g., 20 0C to 25 0C) for a period of at least about 30 minutes. The mixture is optionally filtered to remove the iodine and obtain a filtrate that comprises the polysaccharide dialdehyde. Alternatively, the iodine may be removed by allowing it to sublime.
Next, a first organic solvent is added to either the mixture or the filtrate in an amount sufficient to cause at least some of the polysaccharide dialdehyde to separate from the mixture or the filtrate, thereby forming a first phase comprising the polysaccharide and a second phase comprising the organic solvent. Ideally, substantially all of the polysaccharide dialdehyde is separated from the mixture or the filtrate. Suitable first organic solvents include, but are not limited to, acetone, methyl ethyl ketone, tetrahydrofuran (THF), methanol, ethanol, and isopropanol. In one embodiment the first organic solvent is acetone. The amount of the first organic solvent will vary depending on the conditions, and the optimum amount can be readily determined using routine experimentation by one skilled in the art. Typically, the amount of first organic solvent used is about three times the mass of the reaction mixture or the filtrate. This step is typically done at room temperature (e.g., 20 0C to 25 °C) for a time of at least about 30 minutes. At least a portion of the first phase is separated from the second phase using methods known in the art (e.g., filtering, decanting, centrifuging, or siphoning) to provide a separated polysaccharide dialdehyde. Ideally, substantially all of the first phase is separated from the second phase.
The separated polysaccharide dialdehyde is then contacted with an amount of a second organic solvent sufficient to harden the separated polysaccharide dialdehyde, thereby forming a hardened polysaccharide dialdehyde. Suitable second organic solvents include, but are not limited to, methanol, ethanol, isopropanol, butanol, and acetonitrile. In one embodiment the second organic solvent is methanol. The amount of the second organic solvent will vary depending on the conditions, and the optimum amount can be readily determined using routine experimentation by one skilled in the art. Typically the amount of second organic solvent used is from about 25% to about 100% of the volume of the first organic solvent, as described above.
The hardened polysaccharide dialdehyde is comminuted to form a particulate polysaccharide dialdehyde. The comminuting reduces the particulate polysaccharide to a powder and can be done using methods known in the art, for example, grinding, milling, or crushing with a mortar and pestle. Optionally, the particulate polysaccharide dialdehyde may be dried using any suitable method, for example, using heat, vacuum, a combination of heat and vacuum, or flowing a stream of dry air or a dry inert gas such as nitrogen over the particulate polysaccharide dialdehyde. The particulate polysaccharide dialdehyde is then contacted with a cold aqueous liquid at a temperature of less than about 10 0C, preferably from about -15 0C to about 5 0C, for a time sufficient to remove at least some of the iodine-containing species from the particulate polysaccharide dialdehyde, thereby forming a purified polysaccharide dialdehyde. Ideally, substantially all of the iodine-containing species are removed from the particulate polysaccharide. The cold aqueous liquid may be pure water or comprise a mixture of water and a water-soluble organic solvent such as methanol, ethanol, or isopropanol. If a mixture of water and a water- miscible organic solvent is used, the mixture contains less than or equal to about 50% of the water-miscible organic solvent by volume, preferably from about 5% to about 50% by volume. In one embodiment, the cold aqueous liquid is pure water at a temperature of about 0 0C to about 5 0C. In another embodiment, the cold aqueous liquid is a mixture comprising water and 30 to 40% methanol by volume at a temperature of about -15 0C to about 5 0C. The time of contacting needs to be optimized to maximize the purity of the polysaccharide dialdehyde while minimizing its loss due to dissolution in the cold aqueous liquid. The solubility and the rate of dissolution of the polysaccharide dialdehyde in the cold aqueous liquid depend on several factors such as its molecular weight and degree of oxidation. Typically, the contact time is from about 30 seconds to about 4 hours, preferably from about 10 minutes to about 60 minutes. At least a portion of the purified polysaccharide dialdehyde is then recovered from the cold aqueous liquid using filtering, decanting, centrifuging, siphoning, or the like. Ideally, substantially all of the purified polysaccharide dialdehyde is recovered from the cold aqueous liquid. Optionally, the contacting with cold aqueous liquid may be repeated one or more times. Optionally, the purified polysaccharide dialdehyde may be dried using any suitable method, for example, using heat, vacuum, a combination of heat and vacuum, or flowing a stream of dry air or a dry inert gas such as nitrogen over the purified polysaccharide dialdehyde. In one embodiment, the purified polysaccharide dialdehyde is dried in a vacuum oven at 20 °C for about 16 to 24 hours. In another embodiment, the product of the oxidation reaction is not cooled to a temperature below about 5 0C, i.e., the optional first step is omitted, and the method is followed as described above from the step that comprises adding a source of at least one cation that is capable of precipitating at least a portion of the iodate. Ideally, the cation(s) is/are capable of precipitating substantially all of the iodate. Specifically, a source of at least one cation is added to the product of the oxidation reaction, thereby forming a precipitate comprising the cation(s) and iodate, and a supernatant fluid. Then, at least a portion of the precipitate is separated from the supernatant fluid using methods as described above. Ideally, substantially all of the precipitate is separated from the supernatant fluid. Next, at least one iodide salt is added to the supernatant fluid thereby forming a mixture comprising the polysaccharide dialdehyde and molecular iodine. The mixture is optionally filtered to obtain a filtrate. A first organic solvent is added to the mixture or the filtrate in an amount sufficient to cause at least some of the polysaccharide dialdehyde to separate from the mixture or the filtrate, thereby forming a first phase comprising the polysaccharide dialdehyde and a second phase comprising the organic solvent. Ideally, substantially all of the polysaccharide dialdehyde is separated from the mixture or the filtrate. At least a portion of the first phase is separated from the second phase using methods as described above, to provide a separated polysaccharide dialdehyde. Ideally, substantially all of the first phase is separated from the second phase. The separated polysaccharide dialdehyde is then contacted with an amount of a second organic solvent sufficient to harden the separated polysaccharide dialdehyde, thereby forming a hardened separated polysaccharide dialdehyde. The hardened polysaccharide dialdehyde is comminuted to form particulate polysaccharide dialdehyde. Optionally, the particulate polysaccharide dialdehyde may be dried as described above. The particulate polysaccharide dialdehyde is then contacted with a cold aqueous liquid at a temperature below about 10 0C for a time sufficient to remove at least some iodine containing species from the particulate polysaccharide dialdehyde, thereby forming a purified polysaccharide dialdehyde. Ideally, substantially all of the iodine containing species are removed from the particulate polysaccharide dialdehyde. The contacting with cold aqueous liquid may be repeated one or more times. Then at least a portion of the purified polysaccharide dialdehyde is recovered as described above. Ideally, substantially all of the purified polysaccharide dialdehyde is recovered. Optionally, the purified polysaccharide dialdehyde may be dried, as described above.
The amount of iodine-containing species remaining in the purified polysaccharide dialdehyde can be determined using methods known in the art. For example, the total amount of elemental iodine in any form remaining in the purified polysaccharide dialdehyde can be determined using X-ray fluorescence spectrometry. Typically, the amount of elemental iodine remaining in the polysaccharide dialdehyde produced by the method disclosed herein is less than about 0.03 wt%. After the purified polysaccharide dialdehyde is recovered and optionally dried, it may be used to prepare hydrogel adhesives for medical applications by reacting it in an aqueous medium with a polyamine having three or more amine groups. For example, the purified polysaccharide dialdehyde may be reacted with a water-dispersible, multi-arm polyether amine to form a hydrogel tissue adhesive as described by Kodokian et al. (copending and commonly owned U.S. Patent Application Publication No. 2006/0078536, which is incorporated herein by reference). The resulting hydrogel may be used for medical and veterinary applications, including, but not limited to, wound closure, supplementing or replacing sutures or staples in internal surgical procedures such as intestinal anastomosis and vascular anastomosis, tissue repair, ophthalmic procedures, drug delivery, and in anti-adhesive applications.
EXAMPLES The present invention is further defined in the following Examples. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various uses and conditions.
The meaning of abbreviations used is as follows: "min" means minute(s), "h" means hour(s), "sec" means second(s), "d" means day(s), "mL" means milliliter(s), "L" means liter(s), "μl_" means microliter(s), "cm" means centimeter(s), "mm" means millimeter(s), "μm" means micrometer(s), "cm3" means cubic centimeter, "mol" means mole(s), "mmol" means millimole(s), "g" means gram(s), "kg" means kilogram(s), "mg" means milligram(s), "meq" means milliequivalent(s), "Mw" means weight-average molecular weight, "wt%" means percent by weight, and "NMR' means nuclear magnetic resonance spectrometry.
EXAMPLE 1 Preparation of Dextran Dialdehyde Having an Average Molecular Weight of 8,500 to 11 ,5000
The purpose of this Example was to prepare dextran dialdehyde having an average molecular weight of 8,500 to 11 ,500 Daltons and a total iodine content of less than 0.03 wt%.
In a 1 L glass reactor vessel equipped with a mechanical stirrer and an addition funnel, 37.5 g of sodium periodate and 350 ml_ of deionized water were added. The reactor contents were stirred until all the solids dissolved. The reactor was cooled to 20 0C. Using the addition funnel, a solution containing 37.5 g of dextran (average molecular weight 8,500 - 11 ,500; Sigma Chemical Co, St Louis, MO, catalog no. D9260) dissolved in 300 mL of deionized water was added to the periodate solution. After completing the addition, the reactor contents were stirred for 5 h at 20 0C. At the end of the reaction period, the reactor contents were transferred to a beaker and the beaker was chilled in an ice/acetone bath until a precipitate comprising a periodate salt was formed. The mixture was then transferred back to the reactor and stirred for 30 min at 2 0C. Then, the reactor contents were filtered, yielding 17.13 g of solids. The filtrate was transferred to a beaker and 18.75 g of CaCI2.2H2O was added to the filtrate. The mixture was stirred for 30 min at room temperature forming a precipitate comprising calcium iodate. The precipitate was filtered, yielding 21.45 g of solids. The filtrate was transferred to a beaker and 15.0 g of potassium iodide was added to the filtrate. The mixture was stirred for 30 min at room temperature. The mixture was filtered, but did not result in any detectable amount of solids being collected. The filtrate was transferred to a plastic jug and 2 L of acetone was slowly added to separate the dextran dialdehyde from the filtrate. The contents in the jug were stirred for 30 min, after which time the acetone was decanted off to collect the precipitated solid. The solids were washed with methanol (1 L) and transferred to a blender to be chopped at high speed in the presence of methanol. The solids were filtered and dried under vacuum. Next, 10 g of the solids was mixed in a blender with 200 ml_ of water and 200 cm3 of ice. The blender was stirred for 1 min; then, the mixture was filtered to collect about 8.51 g of solids. The dialdehyde content of the product was determined to be about 51% using proton NMR.
The solid product was analyzed using X-ray fluorescence spectrometry and was found to contain 0.215 wt% chlorine, 0.017 wt% iodine, 0.198 wt% calcium, 0.0272 wt% sodium and 0.237 wt% potassium, and an overall purity of 99.02 wt%. EXAMPLE 2
Preparation of Dextran Dialdehvde Having an Average
Molecular Weight of 60.000 to 90,000
The purpose of this Example was to prepare dextran dialdehyde having an average molecular weight of 60,000 to 90,000 Daltons and a total iodine content of less than 0.03 wt%.
The procedure described in Example 1 was used except that the dextran had an average molecular weight of 60,000 to 90,000 Daltons (Sigma Chemical Co, St Louis, MO, catalog no. D3759) and the amount of sodium periodate used was 18.75 g. The dialdehyde content of the product was determined to be 28% using proton NMR. The solid product was analyzed using X-ray fluorescence spectrometry and was found to contain 0.225 wt% chlorine, 0.019 wt% iodine, 0.0475 wt% calcium, and 0.185 wt% potassium, and an overall purity of 99.98 wt%. EXAMPLE 3
Preparation of Dextran Dialdehvde Having an Average Molecular Weight of 60.000 to 90,000 and an Extent of Oxidation of About 27% without the
Optional Initial Cooling Step The purpose of this Example was to prepare dextran dialdehyde having an average molecular weight of 60,000 to 90,000 Daltons, an extent of oxidation of about 27%, and a total iodine content of less than 0.03 wt%. The purification process did not involve the optional initial cooling to a crystallization temperature below about 5 °C to form a precipitate comprising at least one periodate salt.
A 20-L reactor equipped with a mechanical stirrer, addition funnel, internal thermocouple, and nitrogen purge was charged with 1.00 kg of dextran and 9.00 L of water. The mixture was stirred at ambient temperature to dissolve the dextran, and the solution was cooled to 10-15 0C. A solution of 500 g of sodium periodate in 9.00 L of water was added to the reactor over about an hour while keeping the temperature of the reactor contents below 25 0C. After the sodium periodate solution was added, the mixture was stirred at 20-25 °C for 4 h. At the end of the reaction period, 350 g of CaCI2-2H2O was added to the reaction mixture and the mixture was stirred at ambient temperature for 1 h, forming a precipitate comprising calcium iodate. The mixture was filtered to remove the precipitate, and 200 g of potassium iodide was added to the filtrate. The potassium iodide-containing filtrate was stirred at ambient temperature for 30 min and then filtered, giving a second filtrate. A 5- gallon, plastic pail equipped with a mechanical stirrer was charged with 9.0 L of acetone. About 3.0 L of the second filtrate was added to the acetone over about 15 min with stirring, producing a soft, rubbery precipitate. The supernatant liquid was decanted, and the rubbery precipitate was collected. The rest of the second filtrate was processed similarly, adding it in portions to acetone, stirring, and decanting to collect the precipitate. The combined precipitate from acetone was broken up into pieces and washed in portions with methanol in a large stainless steel blender. The precipitated dextran dialdehyde was collected by filtration, dried under vacuum with a nitrogen blanket, and hammer-milled to a fine powder. A 20-L reactor was charged with 18.0 L of deionized water and cooled to about 0 0C. The hammer-milled dextran dialdehyde was added and stirred vigorously for 1 h. The slurry of dextran dialdehyde in cold water was discharged in portions and filtered to collect the solid, which was immediately washed with methanol to remove water from the product. The solid was dried under vacuum with a nitrogen purge to give 789 g of white, granular dextran dialdehyde. The dialdehyde content of the product was determined to be 27% using proton NMR.
The solid product was analyzed using X-ray fluorescence spectrometry and was found to contain 0.271 wt% sodium, 0.0922 wt% chlorine, 0.0723 wt% potassium, 0.0327 wt% calcium and 0.0068 wt% iodine, and an overall purity of 99.2 wt%.

Claims

CLAIMS What is claimed is:
1. In a method for making a polysaccharide dialdehyde by a process that comprises reacting a polysaccharide with at least one periodate salt at a temperature above about 10 0C to produce a product comprising said polysaccharide dialdehyde, iodate in the form of at least one iodate salt, and optionally periodate in the form of at least one unreacted periodate salt, the improvement comprising the steps of: a) adding a source of at least one cation, which is capable of precipitating at least a portion of the iodate, to said product thereby forming a precipitate comprising said at least one cation and iodate, and a supernatant fluid that comprises the polysaccharide dialdehyde; b) separating at least a portion of the precipitate from the supernatant fluid; c) adding at least one iodide salt to the supernatant fluid thereby forming a mixture comprising the polysaccharide dialdehyde and molecular iodine; d) optionally filtering the mixture to obtain a filtrate; e) adding a first organic solvent to the mixture of (c) or the filtrate of (d) in an amount sufficient to cause at least some of the polysaccharide dialdehyde to separate from the mixture of (c) or the filtrate of (d), thereby forming a first phase comprising the polysaccharide dialdehyde and a second phase comprising the organic solvent; f) separating at least a portion of the first phase from the second phase to provide a separated polysaccharide dialdehyde; g) contacting the separated polysaccharide dialdehyde with an amount of a second organic solvent sufficient to harden the separated polysaccharide dialdehyde, thereby forming hardened polysaccharide dialdehyde; h) comminuting the hardened polysaccharide dialdehyde to form particulate polysaccharide dialdehyde; i) contacting the particulate polysaccharide dialdehyde with a cold aqueous liquid at a temperature of less than about 10 0C for a time sufficient to remove at least some iodine-containing species from the particulate polysaccharide dialdehyde, thereby forming a purified polysaccharide dialdehyde; and j) recovering at least a portion of the purified polysaccharide dialdehyde from the cold aqueous liquid.
2. The method according to Claim 1 further comprising drying the purified polysaccharide dialdehyde after step (j).
3. The method according to Claim 1 wherein the polysaccharide is selected from the group consisting of dextran, starch, cellulose, hemicellulose, methyl cellulose, ethyl cellulose, chondroitin sulfate, dextran sulfate, and hyaluronic acid.
4. The method according to Claim 1 wherein the polysaccharide is dextran.
5. The method according to Claim 1 wherein the source of at least one cation in step (a) is at least one soluble salt comprising a cation selected from the group consisting of Ca2+, Sr2+, Ba2+, Mn2+, Cu2+, Zn2+, Pb2+, Ag+, Cd2+, and Hg2+.
6. The method according to Claim 5 wherein the at least one soluble salt is selected from the group consisting of calcium chloride, calcium acetate, calcium bromide, strontium chloride, strontium acetate, barium chloride, barium acetate, manganese chloride, manganese acetate, cupric chloride, cupric acetate, zinc chloride, zinc acetate, silver nitrate, cadmium chloride, cadmium acetate, lead chloride, lead acetate, mercuric chloride, and mercuric acetate.
7. The method according to Claim 5 wherein the at least one soluble salt is calcium chloride.
8. The method according to Claim 1 wherein the separating of (b) is by filtering, decanting, centrifuging, or siphoning.
9. The method according to Claim 1 wherein the at least one iodide salt of (c) is selected from the group consisting of sodium iodide, potassium iodide, lithium iodide, calcium iodide, and ammonium iodide.
10. The method according to Claim 1 wherein the at least one iodide salt of (c) is potassium iodide.
11. The method according to Claim 1 wherein the first organic solvent of (e) is selected from the group consisting of acetone, methyl ethyl ketone, tetrahydrofuran, methanol, ethanol, and isopropanol.
12. The method according to Claim 1 wherein the first organic solvent of (e) is acetone.
13. The method according to Claim 1 wherein the separating of (T) is by filtering, decanting, centrifuging, or siphoning.
14. The method according to Claim 1 wherein the second organic solvent of (g) is selected from the group consisting of methanol, ethanol, isopropanol, butanol, and acetonitrile.
15. The method according to Claim 1 wherein the second organic solvent of (g) is methanol.
16. The method according to Claim 1 wherein the comminuting of (h) is by grinding, milling, or crushing.
17. The method according to Claim 1 wherein step (i) is repeated one or more times.
18. The method according to Claim 1 wherein the recovering of (j) is by: filtering, decanting, centrifuging, or siphoning.
19. The method according to Claim 1 wherein the cold aqueous liquid of (i) is pure water at a temperature of about 0 0C to about 5 0C.
20. The method according to Claim 1 wherein the cold aqueous liquid of (i) is a mixture of water and from about 5% to about 50% methanol by volume at a temperature of about -15 0C to about 5 0C.
21. In a method for making a polysaccharide dialdehyde by a process that comprises reacting a polysaccharide with at least one periodate salt at a temperature above about 10 0C to produce a product comprising said polysaccharide dialdehyde, iodate in the form of at least one iodate salt, and optionally periodate in the form of at least one unreacted periodate salt, the improvement comprising the steps of: a) cooling said product to a crystallization temperature below about 5 0C and maintaining said product at the crystallization temperature for a time sufficient to form a precipitate comprising at least one periodate salt and a first supernatant fluid that comprises polysaccharide dialdehyde; b) separating at least a portion of the precipitate from the first supernatant fluid; c) adding a source of at least one cation, which is capable of precipitating at least a portion of the iodate, to the first supernatant fluid thereby forming a second precipitate comprising said at least one cation and iodate, and a second supernatant fluid that comprises the polysaccharide dialdehyde; d) separating at least a portion of the second precipitate from the second supernatant fluid; e) adding at least one iodide salt to the second supernatant fluid thereby forming a mixture comprising the polysaccharide dialdehyde and molecular iodine; f) optionally filtering the mixture to obtain a filtrate; g) adding a first organic solvent to the mixture of (e) or the filtrate of (T) in an amount sufficient to cause at least some of the polysaccharide dialdehyde to separate from the mixture of (e) or the filtrate of (f), thereby forming a first phase comprising the polysaccharide dialdehyde and a second phase comprising the organic solvent; h) separating at least a portion of the first phase from the second phase to provide a separated polysaccharide dialdehyde; i) contacting the separated polysaccharide dialdehyde with an amount of a second organic solvent sufficient to harden the separated polysaccharide dialdehyde, thereby forming hardened polysaccharide dialdehyde; j) comminuting the hardened polysaccharide dialdehyde to form particulate polysaccharide dialdehyde; k) contacting the particulate polysaccharide dialdehyde with a cold aqueous liquid at a temperature of less than about 10 0C for a time sufficient to remove at least some iodine containing species from the particulate polysaccharide dialdehyde, thereby forming a purified polysaccharide dialdehyde; and
I) recovering at least a portion of the purified polysaccharide dialdehyde from the cold aqueous liquid.
22. The method according to Claim 21 wherein the cooling of (a) is at a temperature between about 2 0C and about -8 0C.
23. The method according to Claim 21 further comprising: drying the purified polysaccharide dialdehyde after step (I).
24. The method according to Claim 21 wherein the polysaccharide is selected from the group consisting of dextran, starch, cellulose, hemicellulose, methyl cellulose, ethyl cellulose, chondroitin sulfate, dextran sulfate, and hyaluronic acid.
25. The method according to Claim 21 wherein the polysaccharide is dextran.
26. The method according to Claim 21 wherein the separating of (b) is by filtering, decanting, centrifuging, or siphoning.
27. The method according to Claim 21 wherein the source of at least one cation in step (c) is at least one soluble salt comprising a cation selected from the group consisting of Ca2+, Sr2+, Ba2+, Mn2+, Cu2+, Zn2+, Pb2+, Ag+ , Cd2+, and Hg2+.
28. The method according to Claim 27 wherein the at least one soluble salt is selected from the group consisting of to calcium chloride, calcium acetate, calcium bromide, strontium chloride, strontium acetate, barium chloride, barium acetate, manganese chloride, manganese acetate, cupric chloride, cupric acetate, zinc chloride, zinc acetate, silver nitrate, cadmium chloride, cadmium acetate, lead chloride, lead acetate, mercuric chloride, and mercuric acetate.
29. The method according to Claim 27 wherein the at least one soluble salt is calcium chloride.
30. The method according to Claim 21 wherein the separating of (d) is by filtering, decanting, centrifuging, or siphoning.
31. The method according to Claim 21 wherein the at least one iodide salt of (e) is selected from the group consisting of sodium iodide, potassium iodide, lithium iodide, calcium iodide, and ammonium iodide.
32. The method according to Claim 21 wherein the at least one iodide salt of (e) is potassium iodide.
33. The method according to Claim 21 wherein the first organic solvent of (g) is selected from the group consisting of acetone, methyl ethyl ketone, tetrahydrofuran, methanol, ethanol, and isopropanol.
34. The method according to Claim 21 wherein the first organic solvent of (g) is acetone.
35. The method according to Claim 21 wherein the separating of (h) is by filtering, decanting, centrifuging, or siphoning.
36. The method according to Claim 21 wherein the second organic solvent of (i) is selected from the group consisting of methanol, ethanol, isopropanol, butanol, and acetonitrile.
37. The method according to Claim 21 wherein the second organic solvent of (i) is methanol.
38. The method according to Claim 21 wherein the comminuting of Q) is by grinding, milling, or crushing.
39. The method according to Claim 21 wherein step (k) is repeated one or more times.
40. The method according to Claim 21 wherein the recovering of (I) is by: filtering, decanting, centrifuging, or siphoning.
41. The method according to Claim 21 wherein the cold aqueous liquid of (k) is pure water at a temperature of about 0 0C to about 5 0C.
42. The method according to Claim 21 wherein the cold aqueous liquid of (k) is a mixture of water and from about 5% to about 50% methanol by volume at a temperature of about -15 0C to about 5 0C.
43. The method according to Claim 21 wherein after the cooling of (a), the product is maintained at a second crystallization temperature below about 5 0C, which is different from the crystallization temperature of (a), to crystallize the precipitate.
44. In a method for making dextran dialdehyde by a process that comprises reacting dextran with sodium periodate at a temperature about 20 0C to produce a product comprising said dextran dialdehyde, iodate in the form of at least one iodate salt, and optionally periodate in the form of at least one unreacted periodate salt, the improvement comprising the steps of: a) cooling said product to a crystallization temperature between about 2 0C and -8 °C, and maintaining said product at the crystallization temperature for a time sufficient to form a precipitate comprising at least one periodate salt and a first supernatant fluid that comprises dextran dialdehyde; b) separating at least a portion of the precipitate from the first supernatant fluid; c) adding calcium chloride to the first supernatant fluid thereby forming a second precipitate comprising calcium and iodate, and a second supernatant fluid that comprises the dextran dialdehyde; d) separating at least a portion of the second precipitate from the second supernatant fluid; e) adding potassium iodide to the second supernatant fluid thereby forming a mixture comprising the dextran dialdehyde and molecular iodine; f) optionally filtering the mixture to obtain a filtrate; g) adding acetone to the mixture of (e) or the filtrate of (f) in an amount sufficient to cause at least some of the dextran dialdehyde to separate from the mixture of (e) or the filtrate of (T), thereby forming a first phase comprising the dextran dialdehyde and a second phase comprising acetone; h) separating at least a portion of the first phase from the second phase to provide a separated dextran dialdehyde; i) contacting the separated dextran dialdehyde with an amount of a methanol sufficient to harden the separated dextran dialdehyde, thereby forming hardened dextran dialdehyde; j) grinding the hardened polysaccharide dialdehyde to form particulate polysaccharide dialdehyde; k) contacting the particulate dextran dialdehyde with cold water at a temperature of about 0 0C to about 5 0C for a time sufficient to remove at least some iodine containing species from the particulate dextran dialdehyde, thereby forming a purified dextran dialdehyde;
I) recovering at least a portion of the purified dextran dialdehyde from the cold water; and m) drying the purified dextran dialdehyde.
EP08743049A 2007-04-24 2008-04-18 Method for making a polysaccharide dialdehyde having high purity Withdrawn EP2137219A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92594807P 2007-04-24 2007-04-24
PCT/US2008/005013 WO2008133847A1 (en) 2007-04-24 2008-04-18 Method for making a polysaccharide dialdehyde having high purity

Publications (1)

Publication Number Publication Date
EP2137219A1 true EP2137219A1 (en) 2009-12-30

Family

ID=39615615

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08743049A Withdrawn EP2137219A1 (en) 2007-04-24 2008-04-18 Method for making a polysaccharide dialdehyde having high purity

Country Status (4)

Country Link
EP (1) EP2137219A1 (en)
JP (1) JP2010525140A (en)
CN (1) CN101663328A (en)
WO (1) WO2008133847A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2349357B1 (en) 2008-11-19 2012-10-03 Actamax Surgical Materials LLC Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
EP2358761B1 (en) * 2008-12-15 2015-08-05 Council of Scientific & Industrial Research A transparent xyloglucan/chitosan gel and a process for the preparation thereof
USRE46234E1 (en) 2009-03-27 2016-12-13 Actamax Surgical Materials, Llc Tissue adhesive and sealant comprising polyglycerol aldehyde
WO2011002956A1 (en) 2009-07-02 2011-01-06 E. I. Du Pont De Nemours And Company Aldehyde-functionalized polysaccharides
WO2011002888A2 (en) 2009-07-02 2011-01-06 E. I. Du Pont De Nemours And Company Hydrogel tissue adhesive for medical use
US20130274225A1 (en) * 2010-07-19 2013-10-17 Actamax Surgical Materials, Llc Method for making a polysaccharide dialdehyde having high purity
GB201114948D0 (en) 2011-08-31 2011-10-12 Ecosynth Bvba Method to modify carbohydrates
CN103030701B (en) * 2012-12-05 2015-07-08 深圳先进技术研究院 Preparation method of modified starch crosslinking agent
CN103709267A (en) * 2013-11-28 2014-04-09 江南大学 Preparation method of dialdehyde carboxymethyl chitosan
JP2018513249A (en) * 2015-04-03 2018-05-24 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company Oxidized dextran
JP6811956B2 (en) * 2016-09-06 2021-01-13 国立大学法人北陸先端科学技術大学院大学 Decomposition controllable hydrogel
CN106835367B (en) * 2017-02-23 2019-04-16 东北师范大学 A kind of cross-linked polysaccharides fiber and preparation method thereof
JP2023160131A (en) * 2022-04-21 2023-11-02 カーリットホールディングス株式会社 Polyaldehyde compound-containing composition and method for producing the same
GB202211551D0 (en) * 2022-08-08 2022-09-21 Innospec Ltd Composition
CN118697011B (en) * 2024-06-04 2024-12-03 广东中耀环境科技有限公司 A kind of high-dispersion basic copper chloride and preparation method thereof
FR3164461A1 (en) 2024-07-10 2026-01-16 IFP Energies Nouvelles Process for separating and purifying a solution of water-soluble natural polymers containing salts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2251129A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
ATE281408T1 (en) * 1999-06-07 2004-11-15 Sca Hygiene Prod Zeist Bv METHOD FOR REGENERATING PERIODIC ACID
DE10152407A1 (en) 2001-10-24 2003-05-08 Aesculap Ag & Co Kg Composition of at least two biocompatible chemically crosslinkable components
CN101035572B (en) 2004-10-07 2010-12-08 纳幕尔杜邦公司 Polysaccharide-based polymer tissue adhesives for medical use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008133847A1 *

Also Published As

Publication number Publication date
JP2010525140A (en) 2010-07-22
CN101663328A (en) 2010-03-03
WO2008133847A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
WO2008133847A1 (en) Method for making a polysaccharide dialdehyde having high purity
WO2012012359A1 (en) Method for making a polysaccharide dialdehyde having high purity
CN103724455A (en) Hyaluronic acid derivative and preparation method for hyaluronic acid hydrogel
EP1419792A1 (en) Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same
WO2008071058A1 (en) Mercapto-group modified macromolecule derivative and cross-linked material
JPH0796181A (en) Superabsorbent, process for preparation thereof and hygienicgoods having the same
WO2019011061A1 (en) New type water-soluble natural polysaccharide antibacterial material and preparation method therefor
EP0212145B1 (en) Quaternary ammonium salts of natural polysaccharides possessing hypocholesterolemic activity
WO2010118285A1 (en) Method of dissolving an oxidized polysaccharide in an aqueous solution
CN112812201B (en) Thiol-modified hyaluronic acid and preparation method and application thereof
WO2012103445A2 (en) Convalently cross linked hydrogels and methods of making and using same
CN104710653A (en) Chitosan hydrogel and preparation method and application thereof
AU658986B2 (en) N-substituted chitosan derivatives, process for their preparation and the use thereof
US20030055211A1 (en) Chitosan condensation products, their preparation and their uses
CN100494223C (en) Synthesis method of chitosan nucleophilic NO donor modified by quaternary ammonium salt
JPS6219897B2 (en)
JP2015143311A (en) Method for producing cyclodextrin grafted chitosan
WO2019192628A2 (en) Thiolated chitosan derivative, chitosan hydrogel, and preparation methods therefor and applications thereof
CN110343263A (en) A method of based on potassium hydroxide and dissolution in low temperature chitosan
DE2813921C2 (en) Process for the production of ionic pullulangels and their use as molecular sieves for separation and purification
CN101704906A (en) Method for one-step synthesis of chitosan graft polycaprolactone cationic copolymer and application thereof
CN114835826B (en) Zwitterionic cellulose and preparation method and application thereof
US20130303748A1 (en) Method for making aldehyde-functionalized polysaccharides
CN101003632A (en) Method for preparing chitosan - grafting polylactic acid
CN100523002C (en) Chitin/polydioxide cyclohexanone graft copolymer and its production

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090930

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100908

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ACTAMAX SURGICAL MATERIALS LLC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110809